Vol 6, No 2 (2021)
Case report
Published online: 2021-07-01
Challenging multivessel percutaneous coronary intervention supported with Impella 2.5 ventricular assist device
1, 1
, 1, 1
, 1, 1
Disaster Emerg Med J 2021;6(2):90-93.
Abstract
Not available
Keywords: ImpellaPCIMCS
References
- Left Ventricular Assist Devices. SpringerReference. .
- Burzotta F, Russo G, Previ L, et al. Impella: pumps overview and access site management. Minerva Cardioangiol. 2018; 66(5): 606–611.
- Saxena A, Garan AR, Kapur NK, et al. Partial mechanical circulatory support in an ovine model of post-infarction remodeling. J Heart Lung Transplant. 2013; 32(8): 815–822.
- Thiele H, Zeymer U, Neumann FJ, et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14): 1287–1296.
- Bahekar A, Singh M, Singh S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012; 17(1): 44–56.
- Burzotta F, Russo G, Basile E, et al. [How to choose between intra-aortic balloon pump, Impella and extracorporeal membrane oxygenation]. G Ital Cardiol (Rome). 2018; 19(6 Suppl 1): 5S–513S.
- O'Neill WW, Schreiber T, Wohns DHW, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014; 27(1): 1–11.
- Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52(19): 1584–1588.
- Dangas GD, Kini AS, Sharma SK, et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014; 113(2): 222–228.
- Amin AP, Spertus JA, Curtis JP, et al. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. Circulation. 2020; 141(4): 273–284.
- Chieffo A, Ancona MB, Burzotta F, et al. Collaborators. Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry. EuroIntervention. 2020; 15(15): e1343–e1350.
- Alushi B, Douedari A, Froehlig G, et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart. 2019; 6(1): e000987.